HANCOCK JAFFE LABORATORIES
Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of current procedures in concert with a commitment to efficient health care delivery. Founded in 1987 by Norman Jaffe, Hancock Jaffe Laboratories is headquartered in Irvine, California.
HANCOCK JAFFE LABORATORIES
Industry:
Biotechnology Health Care Life Science Medical Device
Founded:
1987-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.hancockjaffe.com
Total Employee:
1+
Status:
Active
Contact:
949-261-2900
Total Funding:
64.1 M USD
Technology used in webpage:
SPF Domain Not Resolving Euro Microsoft Exchange Online Amazon Office 365 Mail COVID-19 Fastly Hosted Fastly Load Balancer Amazon Frankfurt Region
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Hancock Jaffe Laboratories
Official Site Inspections
http://www.hancockjaffe.com
- Host name: 172.67.146.32
- IP address: 172.67.146.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hancock Jaffe Laboratories"
Hancock Jaffe Announces Corporate Rebranding to Reflect …
Sep 21, 2021 - Management to host a conference call with live video webcast at 4:30 p.m. ET today, September 21 st-. IRVINE, CA / ACCESSWIRE / September 21, 2021 / Hancock Jaffe …See details»
Hancock Jaffe Announces Corporate Rebranding to Reflect …
Sep 21, 2021 Interested participants and investors may access the conference call by dialing (877) 407-9708 (domestic) or (201) 689-8259 (international). The live webcast will be …See details»
Hancock Jaffe Announces Corporate Rebranding to Reflect …
Oct 1, 2024 - Hancock Jaffe changing name to enVVeno Medical Corporation and ticker symbol to NASDAQ: NVNO, effective October 1, 2021 - - Development strategy to focus on venous …See details»
Hancock Jaffe to change name and narrow strategic focus
Sep 21, 2021 Hancock Jaffe Laboratories (HJLI) announced that it has changed the name of the company to enVVeno Medical Corporation effective October 1, 2021.As a result, Hancock …See details»
enVVeno Medical Corporation - Crunchbase Company Profile
Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases.See details»
Hancock Jaffe Laboratories Announces $20 Million Registered …
Sep 7, 2021 IRVINE, CA / ACCESSWIRE / September 7, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, …See details»
Hancock Jaffe Announces Intention to Merge with Catheter Precision
Jun 1, 2020 Companies Sign Non-Binding Letter of Intent to Merge. IRVINE, CA / ACCESSWIRE / June 1, 2020 / Hancock Jaffe Laboratories, Inc. (), a developer of medical …See details»
Hancock Jaffe Announces Corporate Rebranding to Reflect
Sep 21, 2021 Interested participants and investors may access the conference call by dialing (877) 407-9708 (domestic) or (201) 689-8259 (international). The live webcast will be …See details»
New Study Confirms Significant Potential U.S. Market for Hancock …
Sep 17, 2018 organization specializing in peripheral vascular disease. The report, titled “Chronic Venous Disease: Epidemiology and Economics” analyzes the size of the addressable market …See details»
Hancock Jaffe Submits IDE Application to FDA for VenoValve U.S.
IRVINE, CA / March 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has …See details»
Hancock Jaffe Laboratories Announces Closings of $6.2 Million …
Jul 21, 2020 IRVINE, CA / ACCESSWIRE / July 21, 2020 / Hancock Jaffe Laboratories, Inc.See details»
Hancock Jaffe Labs - VentureRadar
Similar Companies: AccuMedical China Privately Held AccuMedical is a developer of medical devices.. Scientia Vascular USA Privately Held Scientia Vascular, a Salt Lake City, UT-based …See details»
Hancock Jaffe’s Surgical VenoValve for Treating Chronic Venous ...
August 3, 2021—Hancock Jaffe Laboratories, Inc. announced that the FDA has granted Breakthrough Device designation for the surgically implanted VenoValve as a potential …See details»
Hancock Jaffe Receives Approval for First-in-Human
IRVINE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular …See details»
Hancock Jaffe Laboratories, Inc. Announces Pricing of $5.1 Million ...
Oct 7, 2020 IRVINE, CA / ACCESSWIRE / October 7, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, …See details»
Hancock Jaffe Successfully Starts First-in-Human VenoValve
IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular …See details»
Hancock Jaffe Announces Corporate Rebranding to Reflect …
Sep 21, 2021 www.hancockjaffe.com, and will be archived for 90 days. About Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories (Nasdaq: HJLI) is a medical device company …See details»
Hancock Jaffe Announces Registered Direct Offering Priced At …
Jun 1, 2020 IRVINE, CA / ACCESSWIRE / June 1, 2020 / Hancock Jaffe Laboratories, Inc. (HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular …See details»
Hancock Jaffe to Begin CoreoGraft First-in-Human Study
Oct 14, 2020 IRVINE, CA/ ACCESSWIRE/ October 14, 2020/ Hancock Jaffe Laboratories, Inc., a developer of medical devices that restore cardiac and vascular health, today announced that …See details»
Hancock Jaffe Engages Syntactx for VenoValve U.S. Pivotal Trial
Oct 8, 2020 Syntactx to provide CRO Services IRVINE, CA / ACCESSWIRE / October 8, 2020 / Hancock Jaffe Laboratories, Inc.See details»